Investigating white blood cells to develop new therapies for autoimmune diseases
Investigation of White Blood Cells to Support the Development of Engineered Regulatory T Cell (Treg) Therapies
This study is trying to learn more about white blood cells from volunteers to help create new treatments for autoimmune diseases.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10 (estimated) |
| Sex | All |
| Sponsor | Quell Therapeutics Limited Industry-sponsored |
| Locations | 1 site (London) |
| Trial ID | NCT04838171 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect and analyze white blood cells from volunteer donors to aid in the development of engineered regulatory T cell therapies. By understanding the characteristics and functions of these cells, researchers hope to enhance treatments for conditions such as autoimmune diseases and organ rejection. The study will involve blood collection from participants, with no additional eligibility criteria imposed beyond those set by the consenting institutions.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy volunteers willing to donate white blood cells.
Not a fit: Patients with active autoimmune diseases or those requiring immediate treatment may not benefit from this study.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies that improve outcomes for patients with autoimmune diseases and organ transplant rejections.
How similar studies have performed: While similar studies have explored the use of white blood cells in therapy development, this specific approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
No additional inclusion/ exclusion criteria will be applied by Quell other than those specified by the consenting institutions.
Where this trial is running
London
- Quell Investigator Site 01 — London, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Gareth Wright
- Email: contact@quell-tx.com
- Phone: +4(0)2070969012
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.